Protagonist Therapeutics, Inc (NASDAQ: PTGX)
$36.7500
-0.8700 ( -0.14% ) 173.8K
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Market Data
Open
$36.7500
Previous close
$37.6200
Volume
173.8K
Market cap
$2.20B
Day range
$36.3150 - $38.1840
52 week range
$23.1700 - $48.8900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Sep 12, 2024 |
| 8-k | 8K-related | 15 | Aug 06, 2024 |
| 10-q | Quarterly Reports | 76 | Aug 06, 2024 |
| 4 | Insider transactions | 1 | Jul 26, 2024 |
| 8-k | 8K-related | 14 | Jun 26, 2024 |
| 8-k | 8K-related | 15 | May 07, 2024 |
| 10-q | Quarterly Reports | 58 | May 07, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |